electroCore Revenue and Competitors

Claim your profile

Basking Ridge, NJ USA

Location

$145.5M

Total Funding

Estimated Revenue & Valuation

  • electroCore's estimated annual revenue is currently $4.9M per year.(i)
  • electroCore received $70.0M in venture funding in November 2017.
  • electroCore's estimated revenue per employee is $64,342
  • electroCore's total funding is $145.5M.
  • electroCore's current valuation is $50.8M. (January 2022}

Employee Data

  • electroCore has 76 Employees.(i)
  • electroCore grew their employee count by 21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.8M7N/AN/AN/A
#2
$257M10242%N/AN/A
#3
$11.5M46-12%N/AN/A
#4
$403.6M1608-4%N/AN/A
#5
$8.5M34-3%N/AN/A
#6
$3M120%N/AN/A
#7
$11M44-2%N/AN/A
#8
$20.6M82-8%N/AN/A
#9
$1455.5M57995%N/AN/A
#10
N/A1160%$29.1MN/A

In 2005, we were founded on a unified belief that neuromodulation could be used in novel ways to help patients break free from treatments they aren't happy with. Because different modalities of neuromodulation had previously proven to be effective and safe, we recognized an opportunity to be the leader in this new frontier of medicine and took it head on. Our mission is simplehelp patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments. Bringing new treatments to market will help improve patients' treatment options and lives.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

$145.5M

Total Funding

76

Number of Employees

$4.9M

Revenue (est)

21%

Employee Growth %

$50.8M

Valuation

N/A

Accelerator

electroCore News

2022-04-20 - electroCore Announces Publication of Investigator-Initiated ...

ROCKAWAY, N.J., April 21, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company,...

2022-04-19 - electroCore, Inc. (NASDAQ:ECOR) Expected to Announce ...

electroCore, Inc. (NASDAQ:ECOR) Expected to Announce Earnings of -$0.05 Per Share. Posted by admin on Apr 19th, 2022.

2022-04-13 - electroCore Provides Business Update and Select First ...

electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance. April 12, 2022 08:00 ET | Source: electroCore, Inc. electroCore, Inc.

2017-11-29 - electroCore Completes Over $70M Series B Financing

electroCore, a Basking Ridge, NJ-based bioelectronic medicine healthcare company,, completed an over $70m Series B financing. The round was led by Core Ventures II, with participation from Merck’s Global Health Innovation Fund, Gakasa, American Investment Holdings LLC and the Vinik Family Found ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.7M78-7%N/A
#2
$23.2M868%N/A
#3
N/A87N/AN/A
#4
$13.9M9613%N/A
#5
$14.4M991%N/A

electroCore Funding

DateAmountRoundLead InvestorsReference
2014-07-02$50.0MUndisclosedMerck s Global Health Innovation FundArticle
2016-08-09$1.5MUndisclosedArticle
2017-09-11$36.0MUndisclosedArticle
2017-11-30$70.0MBCore Ventures IIArticle